Coverage of a new PCSK9 trial makes bold claims about prevention and risk reduction. But how well do they hold up to scrutiny ...

Many people who use these medications don’t want to stay on them long term. But research has repeatedly shown that quitting ...

Curious whether kombucha is good for you? The fermented tea offers probiotics and antioxidants that may benefit gut health and overall well-being.

Have you ever searched for information about the side effects of a medication? These days, most people put the name of their drug into a search engine along with the phrase “side effects.” Whatever ...

Last month, the Trump administration announced major plans to slash prices of GLP-1s, including Ozempic, Wegovy, Zepbound, and Mounjaro. The agreement will lower prices of these medications from ...

Q. I was on a 14-day course of prednisone for vertigo. Once I stopped, I had terrible withdrawal symptoms that have persisted for more than 10 days. Luckily, they are getting better, but I’m still ...

A new study finds a possible association between GLP-1 drugs like semaglutide and chronic cough, though the authors are calling for more research. Reading time 2 minutes Every drug has its risks, no ...

Ashwagandha is generally safe and well-tolerated, but may have side effects like nausea, vomiting, drowsiness, and headaches. More serious side effects can include liver problems, increased thyroid ...

More than a third of Americans who were vaccinated against COVID-19 say they had side effects from the shot, and nearly half suspect the vaccines killed many patients, The latest Rasmussen Reports ...

Turn-based roulette games aren’t new, but they continue to be popular due to the development of interesting mechanics and the tense atmosphere that arises from testing your luck. The Side Effects game ...

Researchers discovered another potential side effect that isn't getting nearly as much attention/ What is it and why is it important? Here's what you need to know. 🩺 SIGN UP for Parade’s health ...

NEW ORLEANS -- Adding the PCSK9 inhibitor evolocumab (Repatha) to stable lipid-lowering therapy reduced major adverse cardiac events (MACE) in patients with atherosclerosis or high-risk diabetes, but ...